The Role of the Liver in Sepsis

REFERENCES

• Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6(11):813–822.
   PubMed Web of Science ®Google Scholar
• Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc 2012;60(6):1070–1077.
   PubMed Web of Science ®Google Scholar
• Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest 2006;129(6):1432–1440.
   PubMed Web of Science ®Google Scholar
• Marshall JC. Sepsis: current status, future prospects. Curr Opin Crit Care 2004;10(4):250–264.
   PubMedGoogle Scholar
• Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13(3):260–268.
   PubMed Web of Science ®Google Scholar
• Crouser E, Exline M, Knoell D, Wewers MD. Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des 2008;14(19):1840–1852.
   PubMed Web of Science ®Google Scholar
• Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001;29(7 Suppl):S42–S47.
   Google Scholar
• Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States*. Crit Care Med 2013;41(5):1167–1174.
   PubMed Web of Science ®Google Scholar
• Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care 2008;14(2):189–197.
   PubMedGoogle Scholar
• Jarrar D WP, Chaudry IH. Hepatocellular dysfunction–basic considerations. In: Holzheimer RG MJ, editor. Surgical treatment: evidence-based and problem-oriented. Munich: Zuckschwerdt; 2001.
   Google Scholar
• Recknagel P, Gonnert FA, Westermann M, Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med 2012;9(11):e1001338.
   Google Scholar
• Kramer L, Jordan B, Druml W, Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 2007;35(4):1099–1104.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Angus DC, Artigas A, Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003;31(3):834–840.
   PubMed Web of Science ®Google Scholar
• Cheng B, Xie G, Yao S, Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007;35(11):2538–2546.
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004;30(4):580–588.
   PubMed Web of Science ®Google Scholar
• Blanco J, Muriel-Bombin A, Sagredo V, Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008;12(6):R158.
   PubMedGoogle Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348(16):1546–1554.
   PubMed Web of Science ®Google Scholar
• Seymour CW, Iwashyna TJ, Cooke CR, Marital status and the epidemiology and outcomes of sepsis. Chest 2010;137(6):1289–1296.
   PubMedGoogle Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29(7):1303–1310.
   PubMed Web of Science ®Google Scholar
• Bakker J, Grover R, McLuckie A, Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144–002). Crit Care Med 2004;32(1):1–12.
   PubMedGoogle Scholar
• Weiss YG, Bellin L, Kim PK, Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats. Am J Physiol Gastrointest Liver Physiol 2001;280(5):G968–G973.
   Google Scholar
• Gentilello LM. Alcohol and the intensive care unit: it's not just an antiseptic. Crit Care Med 2007;35(2):627–628.
   PubMedGoogle Scholar
• Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003;124(3):1016–1020.
   PubMed Web of Science ®Google Scholar
• Wong F, Bernardi M, Balk R, Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005;54(5):718–725.
   PubMed Web of Science ®Google Scholar
• Lendemans S, Heuer M, Nast-Kolb D, Significance of liver trauma for the incidence of sepsis, multiple organ failure and lethality of severely injured patients. An organ-specific evaluation of 24,771 patients from the trauma register of the DGU. Unfallchirurg 2008;111(4):232–239.
   PubMedGoogle Scholar
• Koskinas J, Gomatos IP, Tiniakos DG, Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 2008;14(9):1389–1393.
   PubMed Web of Science ®Google Scholar
• Muftuoglu MA, Aktekin A, Ozdemir NC, Saglam A. Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today 2006;36(6):519–524.
   PubMedGoogle Scholar
• Akcan A, Kucuk C, Ok E, The effect of amrinone on liver regeneration in experimental hepatic resection model. J Surg Res 2006;130(1):66–72.
   PubMedGoogle Scholar
• Gonnert F, Bauer M, Kortgen A. Current aspects of diagnostics of hepatic dysfunction in critically ill. Dtsch Med Wochenschr 2012;137(43):2212–2216.
   PubMedGoogle Scholar
• Memis D, Kargi M, Sut N. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study. J Crit Care 2009;24(4):603–608.
   PubMed Web of Science ®Google Scholar
• Koo DJ, Zhou M, Chaudry IH, Wang P. Plasma alpha-glutathione S-transferase: a sensitive indicator of hepatocellular damage during polymicrobial sepsis. Arch Surg 2000;135(2):198–203.
   PubMedGoogle Scholar
• Crouser ED, Julian MW, Huff JE, Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 2006;34(9):2439–2446.
   PubMedGoogle Scholar
• Maitra SR, Wang S, Brathwaite CE, El-Maghrabi MR. Alterations in glucose-6-phosphatase gene expression in sepsis. J Trauma 2000;49(1):38–42.
   PubMedGoogle Scholar
• Gonnert FA, Kunisch E, Gajda M, Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock 2012;37(4):399–407.
   PubMedGoogle Scholar
• Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012;12(3):201–213.
   PubMed Web of Science ®Google Scholar
• Deng M, Scott MJ, Loughran P, Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol 2013;190(10):5152–5160.
   PubMed Web of Science ®Google Scholar
• Ashare A, Stanford C, Hancock P, Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia. Clin Transl Sci 2009;2(3):199–205.
   PubMedGoogle Scholar
• Wasmuth HE, Kunz D, Yagmur E, Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 2005;42(2):195–201.
   PubMed Web of Science ®Google Scholar
• Wong CH, Jenne CN, Petri B, Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013;14(8):785–792.
   PubMed Web of Science ®Google Scholar
• Rauch PJ, Chudnovskiy A, Robbins CS, Innate response activator B cells protect against microbial sepsis. Science 2012;335(6068):597–601.
   PubMed Web of Science ®Google Scholar
• Soji T, Murata Y, Ohira A, Evidence that hepatocytes can phagocytize exogenous substances. Anat Rec 1992;233(4):543–546.
   PubMedGoogle Scholar
• Kirn A, Steffan AM, Anton M, Phagocytic properties displayed by mouse hepatocytes after virus induced damage of the sinusoidal lining. Biomedicine 1978;29(1):25–28.
   PubMedGoogle Scholar
• Seternes T, Dalmo RA, Hoffman J, Scavenger-receptor-mediated endocytosis of lipopolysaccharide in Atlantic cod (Gadus morhua L.). J Exp Biol 2001;204(Pt 23):4055–4064.
   PubMedGoogle Scholar
• Shao B, Munford RS, Kitchens R, Varley AW. Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun 2012;18(6):825–833.
   PubMed Web of Science ®Google Scholar
• Siore AM, Parker RE, Stecenko AA, Endotoxin-induced acute lung injury requires interaction with the liver. Am J Physiol Lung Cell Mol Physiol 2005;289(5):L769–L776.
   Google Scholar
• Gustot T, Durand F, Lebrec D, Severe sepsis in cirrhosis. Hepatology. 2009;50(6):2022–2033.
   PubMed Web of Science ®Google Scholar
• Matuschak GM, Henry KA, Johanns CA, Lechner AJ. Liver-lung interactions following Escherichia coli bacteremic sepsis and secondary hepatic ischemia/reperfusion injury. Am J Respir Crit Care Med 2001;163(4):1002–1009.
   PubMed Web of Science ®Google Scholar
• Koo DJ, Chaudry IH, Wang P. Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J Surg Res 1999;83(2):151–157.
   PubMedGoogle Scholar
• Hu CK, Venet F, Heffernan DS, The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. J Immunol 2009;182(4):2467–2475.
   PubMedGoogle Scholar
• Souza-Fonseca-Guimaraes F, Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: natural killer cells in sepsis –guilty or not guilty? Crit Care 2013;17(4):235.
   PubMedGoogle Scholar
• Wesche-Soldato DE, Chung CS, Gregory SH, CD8+T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol 2007;171(1):87–96.
   PubMedGoogle Scholar
• Bertoletti A, Maini M, Williams R. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res 2003;60(2):61–66.
   PubMed Web of Science ®Google Scholar
• Condotta SA, Rai D, James BR, Sustained and incomplete recovery of naive CD8+T cell precursors after sepsis contributes to impaired CD8+T cell responses to infection. J Immunol 2013;190(5):1991–2000.
   PubMedGoogle Scholar
• Li F, Tian Z. The liver works as a school to educate regulatory immune cells. Cell Mol Immunol 2013;10(4):292–302.
   PubMedGoogle Scholar
• von Baehr V, Docke WD, Plauth M, Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000;47(2):281–287.
   PubMedGoogle Scholar
• Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological “damage limitation” effect and an important potential opportunity for therapy. Curr Med Chem 2006;13(21):2487–502.
   PubMed Web of Science ®Google Scholar
• Uhrig A, Banafsche R, Kremer M, Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005;77(5):626–633.
   PubMedGoogle Scholar
• Diehl L, Schurich A, Grochtmann R, Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+T cell tolerance. Hepatology 2008;47(1):296–305.
   PubMedGoogle Scholar
• Sander LE, Sackett SD, Dierssen U, Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2013;207(7):1453–1464.
   Google Scholar
• Ren D, Bi Q, Li L, Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression. Cell Immunol 2013;279(1):12–20.
   Google Scholar
• Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009;30(10):475–487.
   PubMed Web of Science ®Google Scholar